Cargando…
Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
BACKGROUND: Graft-versus-host disease (GvHD) is the main life-threatening complication of allogeneic hematopoietic stem cell transplantation (HSCT). Thirty to 80% of GvHD patients do not respond to first-line treatment and a second-line treatment is not universally established. Based on their immuno...
Autores principales: | Morata-Tarifa, Cynthia, Macías-Sánchez, María del Mar, Gutiérrez-Pizarraya, Antonio, Sanchez-Pernaute, Rosario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027118/ https://www.ncbi.nlm.nih.gov/pubmed/32070420 http://dx.doi.org/10.1186/s13287-020-01592-z |
Ejemplares similares
-
Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience
por: Macías-Sánchez, María del Mar, et al.
Publicado: (2022) -
Looking backward to move forward: a meta-analysis of stem cell therapy in amyotrophic lateral sclerosis
por: Morata-Tarifa, Cynthia, et al.
Publicado: (2021) -
Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease—A Phase II Study
por: Kuzmina, Larisa A., et al.
Publicado: (2012) -
Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
por: Kelly, Kilian, et al.
Publicado: (2021) -
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
por: Stenger, Elizabeth, et al.
Publicado: (2022)